91 related articles for article (PubMed ID: 24050246)
1. Special Section on Cytochrome P450 Enzymes in Toxicology and as Drug Targets-Editorial.
Zhong XB; Lai Y
Drug Metab Dispos; 2024 May; 52(6):476-478. PubMed ID: 38754960
[No Abstract] [Full Text] [Related]
2. Catalytic and Electrocatalytic Mechanisms of Cytochromes P450 in the Development of Biosensors and Bioreactors.
Koroleva PI; Bulko TV; Agafonova LE; Shumyantseva VV
Biochemistry (Mosc); 2023 Oct; 88(10):1645-1657. PubMed ID: 38105030
[TBL] [Abstract][Full Text] [Related]
3. Analytical and functional aspects of protein-ligand interactions: Beyond induced fit and conformational selection.
Redhair M; Atkins WM
Arch Biochem Biophys; 2021 Dec; 714():109064. PubMed ID: 34715072
[TBL] [Abstract][Full Text] [Related]
4. Regulation of Human Cytochrome P4501A1 (hCYP1A1): A Plausible Target for Chemoprevention?
Santes-Palacios R; Ornelas-Ayala D; Cabañas N; Marroquín-Pérez A; Hernández-Magaña A; Del Rosario Olguín-Reyes S; Camacho-Carranza R; Espinosa-Aguirre JJ
Biomed Res Int; 2016; 2016():5341081. PubMed ID: 28105425
[TBL] [Abstract][Full Text] [Related]
5. Modeling of interactions between xenobiotics and cytochrome P450 (CYP) enzymes.
Raunio H; Kuusisto M; Juvonen RO; Pentikäinen OT
Front Pharmacol; 2015; 6():123. PubMed ID: 26124721
[TBL] [Abstract][Full Text] [Related]
6. Model-based estimates of the effects of efavirenz on bedaquiline pharmacokinetics and suggested dose adjustments for patients coinfected with HIV and tuberculosis.
Svensson EM; Aweeka F; Park JG; Marzan F; Dooley KE; Karlsson MO
Antimicrob Agents Chemother; 2013 Jun; 57(6):2780-7. PubMed ID: 23571542
[TBL] [Abstract][Full Text] [Related]
7. Designing better drugs: predicting cytochrome P450 metabolism.
de Groot MJ
Drug Discov Today; 2006 Jul; 11(13-14):601-6. PubMed ID: 16793528
[TBL] [Abstract][Full Text] [Related]
8. Prediction of cytochrome P450 mediated metabolism.
Olsen L; Oostenbrink C; Jørgensen FS
Adv Drug Deliv Rev; 2015 Jun; 86():61-71. PubMed ID: 25958010
[TBL] [Abstract][Full Text] [Related]
9. The human hepatic cytochromes P450 involved in drug metabolism.
Wrighton SA; Stevens JC
Crit Rev Toxicol; 1992; 22(1):1-21. PubMed ID: 1616599
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of recombinant cytochrome P450 enzymes as an in vitro system for metabolic clearance predictions.
Stringer RA; Strain-Damerell C; Nicklin P; Houston JB
Drug Metab Dispos; 2009 May; 37(5):1025-34. PubMed ID: 19196847
[TBL] [Abstract][Full Text] [Related]
11. Microtiter plate assays for inhibition of human, drug-metabolizing cytochromes P450.
Crespi CL; Miller VP; Penman BW
Anal Biochem; 1997 May; 248(1):188-90. PubMed ID: 9177742
[No Abstract] [Full Text] [Related]
12. Modelling cytochromes P450 binding modes to predict P450 inhibition, metabolic stability and isoform selectivity.
Carosati E
Drug Discov Today Technol; 2013; 10(1):e167-75. PubMed ID: 24050246
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
